Singh, Harinder
Wray, Nathan
Schappi, Jeffrey M.
Rasenick, Mark M.
Article History
Received: 18 October 2017
Revised: 11 January 2018
Accepted: 18 January 2018
First Online: 5 February 2018
Change Date: 7 January 2019
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41386-018-0198-2
Change Date: 5 December 2024
Change Type: Correction
Change Details: This article has been retracted. Please see the Retraction Notice for more detail:
Change Details: https://doi.org/10.1038/s41386-024-02039-2
Conflict of interest
: M.M.R. has received research support from Eli Lilly and Lundbeck, Inc. and is consultant to Otsuka Pharmaceuticals. He also has ownership in Pax Neuroscience. The remaining authors have nothing to disclose. H.S., N.W. and J.S. declare no conflicts of interest.